A kind of 2,3-dehydrosilibinin derivative and its preparation method and application
A technology for dehydrosilibinin and derivatives, which can be used in pharmaceutical combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc., and can solve the problems of low bioavailability, limited application, poor water solubility of silibinin, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Example 1: (Preparation of intermediate)
[0045] Preparation of 7-(2-bromo)ethoxy-2,3-dehydrosilybin
[0046]
[0047] The structural formula of 7-(2-bromo)ethoxy-2,3-dehydrosilybin
[0048] Dissolve 2.41 g (5 mmol) of silybin in 110 ml of acetone, then add 8.5 ml (100 mmol) of 1,2-dibromoethane and 0.345 g (2.5 mmol) of potassium carbonate at 45 ℃ The reaction was stirred for 2 d, monitored by TLC. After the reaction, stop the reaction, spin off the acetone, add 100 ml of water, extract with EA, wash the EA layer with water and saturated sodium chloride respectively, separate the organic layer, dry the organic layer with anhydrous sodium sulfate, filter, and concentrate the filtrate. The silica gel column was separated to obtain 0.63 g of yellow solid, the yield was 21.5%, mp 240.0-242.0°C. Structural identification data: 1 H NMR (400 MHz, DMSO-d 6 ): δ 3.35-3.39(m, 1H), 3.56-3.58 (m, 1H), 3.79 (s, 3H), 3.83 (t, J = 5.2 Hz, 2H), 4.26-4.30(m, 1H), 4.44 (t, J = 5.2 Hz, 2...
Embodiment 2
[0049] Example 2: (Preparation of intermediate)
[0050] Preparation of 7-(3-bromo)propoxy-2,3-dehydrosilybin
[0051]
[0052] The structural formula of 7-(3-bromo)propoxy-2,3-dehydrosilybin
[0053] According to Example 1, 1,3-dibromopropane was used instead of 1,2-dibromoethane to obtain a yellow solid with a yield of 10.2%, mp 214.0-215.0 °C. Structural identification data: 1 H NMR (DMSO-d 6 ): δ 2.25-2.29 (m, 2H), 3.35-3.40 (m,1H), 3.56-3.58 (m, 1H), 3.66 (t, J = 6.4 Hz, 2H), 3.80 (s, 3H), 4.19 (t, J =6.0 Hz, 2H), 4.25-4.28 (m, 1H), 4.96 (d, 1H), 6.35 (d, 1H), 6.81-6.83 (m,2H), 6.89 (d, J = 8.4Hz, 1H), 7.05 (br, 1H), 7.12 (d, J = 9.2 Hz, 1H), 7.80-7.82 (m, 2H).
Embodiment 3
[0055] Preparation of 7-(2-morpholinyl)ethoxy-2,3-dehydrosilybin (compound 1)
[0056]
[0057] Compound 1 structural formula
[0058] Dissolve 0.11 g (0.188 mmol) of 7-(2-bromo)ethoxy-2,3-dehydrosilybin in 4 ml of DMF, then add 33 mg (0.376 mmol) of morpholine, React at 50°C for 12 hours, monitored by TLC. After the reaction, stop the reaction, cool at room temperature, add 30 ml of water, extract with EA, separate the organic layer, wash the organic layer with water and saturated sodium chloride successively, separate the organic layer, dry with anhydrous sodium sulfate, filter, and filtrate Concentrate to obtain 0.11 g of yellow solid residue. Separate on a silica gel column to obtain 0.1 g of yellow solid, yield 90.1%, mp 229.3-232.6 ℃. 1 H NMR (DMSO-d 6 ): δ 2.47 (t, 4H), 2.70 (t, J = 5.6 Hz, 2H), 3.39-3.42 (m, 1H), 3.56-3.58 (m, 1H), 3.57 (t, 4H), 3.79(s, 3H), 4.19 (t, J = 5.6 Hz, 2H), 4.25-4.29 (m, 1H), 4.96 (s, 1H), 4.98(d, 1H), 6.33 (br.s, 1H), 6.81-6.83 (m, 2H), 6.88-...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


